Citation Impact
Citing Papers
Aristolochic acid and the etiology of endemic (Balkan) nephropathy
2007 Standout
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
2009 Standout
An advanced human in vitro co-culture model for translocation studies across the placental barrier
2018
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Protein Kinase C Activation Downregulates Human Organic Anion Transporter 1-Mediated Transport through Carrier Internalization
2003
Kynurenines in the mammalian brain: when physiology meets pathology
2012
Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney
2002
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
2013 Standout
Plasma S/R ratio of warfarin co-varies with VKORC1 haplotype
2007 StandoutNobel
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
2008 Standout
The kynurenine pathway and the brain: Challenges, controversies and promises
2016
Polymorphism of human cytochrome P450 enzymes and its clinical impact
2009
Transport of organic anions across the basolateral membrane of proximal tubule cells
2003
Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues
2009
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
New Insights into Diuretic Use in Patients with Chronic Renal Disease
2002
Oral Anticoagulant Therapy
2012 Standout
Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
2002
Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data
2002
Human Organic Anion Transporter 3 (hOAT3) can Operate as an Exchanger and Mediate Secretory Urate Flux
2003
CYP2C9 Ile359 and Leu359 variants: enzyme kinetic study with seven substrates
2000
Gene Expression Levels and Immunolocalization of Organic Ion Transporters in the Human Kidney
2002
Targeting multidrug resistance in cancer
2006 Standout
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid
2013
Regulation of Renal Organic Anion Transporter 3 (SLC22A8) Expression and Function by the Integrity of Lipid Raft Domains and their Associated Cytoskeleton
2013 Standout
Organic Anion Transporters of the SLC22 Family: Biopharmaceutical, Physiological, and Pathological Roles
2007
The role of short-chain fatty acids in microbiota–gut–brain communication
2019 Standout
Co-localization and interaction of organic anion transporter 1 with caveolin-2 in rat kidney
2005
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Physiology, structure, and regulation of the cloned organic anion transporters
2008
Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies
2007
Pharmacogenetics of Warfarin Elimination and its Clinical Implications
2001
Ochratoxin A: The Continuing Enigma
2005
A review on emerging contaminants in wastewaters and the environment: Current knowledge, understudied areas and recommendations for future monitoring
2014 Standout
Kynurenic acid as an antagonist of α7 nicotinic acetylcholine receptors in the brain: Facts and challenges
2012
Occurrence and fate of emerging contaminants in municipal wastewater treatment plants from different geographical regions-a review
2017 Standout
Regulation of renal tubular secretion of organic compounds
2001
A Species Difference in the Transport Activities of H2 Receptor Antagonists by Rat and Human Renal Organic Anion and Cation Transporters
2005
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
From evidence based medicine to mechanism based medicine. Reviewing the role of pharmacogenetics
2010
Herb-Drug Interactions
2005 Standout
Impact of Drug Transporter Studies on Drug Discovery and Development
2003
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
2018 Standout
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Methotrexate: a detailed review on drug delivery and clinical aspects
2012
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
Organic Anion Transporter Family: Current Knowledge
2006
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy
2020 Standout
CYP2C9 and oral anticoagulation therapy with acenocoumarol and warfarin: similarities yet differences
2004
Clinical relevance of genetic polymorphisms in the human CYP2C subfamily
2001
Q172H Replacement Overcomes Effects on the Metabolism of Cyclophosphamide and Efavirenz Caused by CYP2B6 Variant with Arg262
2011
Transporters involved in the elimination of drugs in the kidney: Organic anion transporters and organic cation transporters
2001
Orthogonal Design of Experiments for Engineering of Lipid Nanoparticles for mRNA Delivery to the Placenta
2023 StandoutNobel
Role of indoleamine 2,3-dioxygenase in health and disease
2015
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2
2005
The Many Roles for Fluorine in Medicinal Chemistry
2008 Standout
Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment
2013 Standout
Generation of sulfate radical through heterogeneous catalysis for organic contaminants removal: Current development, challenges and prospects
2016 Standout
Dietary Folic Acid Promotes Survival of Foxp3+ Regulatory T Cells in the Colon
2012 StandoutNobel
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
Gout
2021 Standout
Identification of simple arylfluorosulfates as potent agents against resistant bacteria
2021 StandoutNobel
Association of Cumulative Cyclosporine Dose with Its Irreversible Nephrotoxicity in Japanese Patients with Pediatric-Onset Autoimmune Diseases
2007
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Honokiol: A Review of Its Anticancer Potential and Mechanisms
2019
Clinical significance of T cell metabolic reprogramming in cancer
2016
CYP2C9*8 is Prevalent Among African–Americans: Implications for Pharmacogenetic Dosing
2009
Xanthurenic Acid Formation from 3-Hydroxykynurenine in the Mammalian Brain: Neurochemical Characterization and Physiological Effects
2017
Combination therapy strategies for improving PD‐1 blockade efficacy: a new era in cancer immunotherapy
2017 StandoutNobel
Protective effect of pentoxyfilline in renal toxicity after methotrexate administration.
2011
Formation of A Dihydroxy Metabolite of Phenytoin in Human Liver Microsomes/cytosol: Roles of Cytochromes P450 2c9, 2c19, and 3a4
2000
Korean red ginseng extract enhances paclitaxel distribution to mammary tumors and its oral bioavailability by P-glycoprotein inhibition
2016
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout
Works of Yuichi Uwai being referenced
Transport of Xanthurenic Acid by Rat/Human Organic Anion Transporters OAT1 and OAT3
2013
Methotrexate-Loxoprofen Interaction: Involvement of Human Organic Anion Transporters hOAT1 and hOAT3
2004
Inhibitory effect of anti-diabetic agents on rat organic anion transporter rOAT1
2000
Functional characterization of the rat multispecific organic anion transporter OAT1 mediating basolateral uptake of anionic drugs in the kidney
1998
Common single nucleotide polymorphisms of the MDR1 gene have no influence on its mRNA expression level of normal kidney cortex and renal cell carcinoma in Japanese nephrectomized patients
2003
Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy*
1997
Different transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A)
2004
Interaction and transport of kynurenic acid via human organic anion transporters hOAT1 and hOAT3
2011
Effects of natural nuclear factor-kappa B inhibitors on anticancer drug efflux transporter human P-glycoprotein
2015
Interaction between methotrexate and nonsteroidal anti-inflammatory drugs in organic anion transporter
2000
Rat Renal Organic Anion Transporter rOAT1 Mediates Transport of Urinary-Excreted Cephalosporins, but not of Biliary-Excreted Cefoperazone
2002
Interaction and Transport of Thiazide Diuretics, Loop Diuretics, and Acetazolamide via Rat Renal Organic Anion Transporter rOAT1
2000
Effects of Antiviral Drugs on Organic Anion Transport in Human Placental BeWo Cells
2015
Stereoselective inhibitory effect of flurbiprofen, ibuprofen and naproxen on human organic anion transporters hOAT1 and hOAT3
2011